154 related articles for article (PubMed ID: 34844917)
1. Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy.
Liao M; Huang Y; Wang J; Meng X; Liu Y; Yu J; Yan H
Br J Ophthalmol; 2023 Apr; 107(4):560-564. PubMed ID: 34844917
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
Hu L; Chen Q; Du Z; Wang W; Zhao G
Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
Jonas JB; Söfker A; Degenring R
Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
[TBL] [Abstract][Full Text] [Related]
4. Erosive Retinopathy and Retinal Detachment From Depot Intravitreal Triamcinolone Acetonide Injection at the End of Pars Plana Vitrectomy.
Sisk RA; Patel YP; Foster RE; Petersen MR
Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):613-619. PubMed ID: 31671193
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy.
Takamura Y; Shimura M; Katome T; Someya H; Sugimoto M; Hirano T; Sakamoto T; Gozawa M; Matsumura T; Inatani M;
Br J Ophthalmol; 2018 Oct; 102(10):1351-1357. PubMed ID: 29343528
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone reduces the morphologic changes of ciliary body after pars plana vitrectomy for retinal vascular diseases.
Lee GH; Ahn JK; Park YG
Am J Ophthalmol; 2008 Jun; 145(6):1037-1044. PubMed ID: 18378211
[TBL] [Abstract][Full Text] [Related]
8. Triamcinolone-assisted pars plana vitrectomy for retinal disease.
Zheng Y; Sun N; Xiong Q; Wang X; Quan Y
Yan Ke Xue Bao; 2005 Sep; 21(3):142-6. PubMed ID: 17162851
[TBL] [Abstract][Full Text] [Related]
9. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
[TBL] [Abstract][Full Text] [Related]
10. [Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide].
Mańkowska A; Rejdak R; Oleszczuk A; Kiczyńska M; Łekawa A; Choragiewicz T; Zagórski Z
Klin Oczna; 2008; 110(4-6):151-4. PubMed ID: 18655452
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
[TBL] [Abstract][Full Text] [Related]
12. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema.
Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ
Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632
[TBL] [Abstract][Full Text] [Related]
13. Diode laser, vitrectomy and intravitreal triamcinolone. A comparative study for the treatment of diffuse non tractional diabetic macular edema.
Parolini B; Panozzo G; Gusson E; Pinackatt S; Bertoldo G; Rottini S; Pignatto S
Semin Ophthalmol; 2004; 19(1-2):1-12. PubMed ID: 15658006
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.
Doi N; Sakamoto T; Sonoda Y; Yasuda M; Yonemoto K; Arimura N; Uchino E; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2012 Jan; 250(1):71-8. PubMed ID: 21853229
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide injection at the time of pars plana vitrectomy for retained lens material.
Kim NR; Yoon JH; Kang SM; Chin HS
Korean J Ophthalmol; 2009 Mar; 23(1):13-6. PubMed ID: 19337473
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
[TBL] [Abstract][Full Text] [Related]
17. Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.
Lee Y; Kang S; Park YH
Korean J Ophthalmol; 2013 Feb; 27(1):28-33. PubMed ID: 23372376
[TBL] [Abstract][Full Text] [Related]
18. [Pars plana vitrectomy and combination therapy pars plana vitrectomy, intravitreal triamcinolon acetonid and macular lasercoagulation - one year results].
Stefaničková J; Strmeň P; Vavrová K; Mrózová L; Krásnik V
Cesk Slov Oftalmol; 2012 Nov; 68(5):180-8. PubMed ID: 23461369
[TBL] [Abstract][Full Text] [Related]
19. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.
Sonoda KH; Sakamoto T; Enaida H; Miyazaki M; Noda Y; Nakamura T; Ueno A; Yokoyama M; Kubota T; Ishibashi T
Ophthalmology; 2004 Feb; 111(2):226-30. PubMed ID: 15019367
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
